1

Unlocking CCL2/MCP-1 Inhibition: The 2H5 Antibody Advantage

recombinant-2h5-mab302349
This increasing area of research highlights on inhibiting CCL2/MCP-1, a key chemokine linked in several inflammatory diseases . Existing approaches often present challenges due to poor specificity or https://www.targetmol.com/compound/anti-mouse-rat-human-ccl2-mcp-1-antibody-2h5
Report this page

Comments

    HTML is allowed

Who Upvoted this Story